Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
3451
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $317K | ﹤0.01% |
+33,900
| New | +$337K |
|
3452
Harte-Hanks
HHS
$16.2M
| $316K | ﹤0.01% |
+41,700
| New | +$299K |
|
|
SUMR
3453
DELISTED
Summer Infant, Inc.
SUMR
| $316K | ﹤0.01% |
27,123
-900
| -3% | -$8.64K |
|
3454
Mativ Holdings
MATV
$481M
| $315K | ﹤0.01% |
11,464
-86,536
| -88% | -$2.61M |
|
3455
Tyra Biosciences
TYRA
$1.9B
| $314K | ﹤0.01% |
29,300
-61,700
| -68% | -$732K |
|
|
ONCR
3456
DELISTED
Oncorus, Inc.
ONCR
| $312K | ﹤0.01% |
175,532
+161,432
| +1,145% | +$452K |
|
|
LOGC
3457
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $312K | ﹤0.01% |
+459,199
| New | +$504K |
|
|
PTVE
3458
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $311K | ﹤0.01% |
+30,964
| New | +$329K |
|
3459
Annovis Bio
ANVS
$74.4M
| $310K | ﹤0.01% |
23,197
+12,697
| +121% | +$183K |
|
3460
USCB Financial Holdings
USCB
$406M
| $310K | ﹤0.01% |
21,615
+8,118
| +60% | +$114K |
|
|
NEXI
3461
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $310K | ﹤0.01% |
2,946
+910
| +45% | +$66.8K |
|
3462
Mexco Energy
MXC
$17.8M
| $308K | ﹤0.01% |
19,000
+2,500
| +15% | +$33.8K |
|
3463
Summit State Bank
SSBI
$83.8M
| $308K | ﹤0.01% |
17,990
-3,700
| -17% | -$60.1K |
|
|
AGR
3464
DELISTED
Avangrid, Inc.
AGR
| $308K | ﹤0.01% |
6,600
-5,600
| -46% | -$257K |
|
|
TOUR
3465
Tuniu
TOUR
$53.9M
| $307K | ﹤0.01% |
34,420
-33,560
| -49% | -$369K |
|
|
REFI
3466
Chicago Atlantic Real Estate Finance
REFI
$248M
| $305K | ﹤0.01% |
+17,200
| New | +$319K |
|
3467
LiveOne
LVO
$61.7M
| $304K | ﹤0.01% |
37,310
-3,380
| -8% | -$29.5K |
|
3468
Ring Energy
REI
$315M
| $303K | ﹤0.01% |
79,362
-1,241,438
| -94% | -$3.81M |
|
3469
Shoals Technologies Group
SHLS
$1.47B
| $303K | ﹤0.01% |
17,800
+400
| +2% | +$6.93K |
|
3470
X4 Pharmaceuticals
XFOR
$375M
| $303K | ﹤0.01% |
5,770
+1,194
| +26% | +$68.5K |
|
|
ELMS
3471
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
| $303K | ﹤0.01% |
+211,723
| New | +$688K |
|
3472
Sphere Entertainment
SPHR
$5.14B
| $300K | ﹤0.01% |
+3,600
| New | +$271K |
|
3473
American Coastal Insurance
ACIC
$515M
| $299K | ﹤0.01% |
90,226
-1,300
| -1% | -$4.92K |
|
|
AUD
3474
DELISTED
Audacy, Inc.
AUD
| $299K | ﹤0.01% |
103,400
+28,959
| +39% | +$76.5K |
|
|
PTRS
3475
DELISTED
Partners Bancorp Common Stock
PTRS
| $297K | ﹤0.01% |
32,300
-900
| -3% | -$8.96K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.